Drug Discovery Technology Alert. Submental Contouring Injectable Drug Receives FDA Nod; Strategic Procedure to Prepare More Reliable Antibody Drug Conjugates; Treatment for Irritable Bowel Syndrome Gets Approval from FDA

USD 950

* Required Fields

USD 950

PAY BY INVOICE

Be the first to review this product

This issue profiles a submental contouring injectable drug that has been approved by FDFA, treatment for irritable bowel syndrome that has obtained FDA approval, and a strategic procedure to prepare more reliable antibody drug conjugates.

Table of Contents

Drug Discovery Technology Alert. Submental Contouring Injectable Drug Receives FDA Nod; Strategic Procedure to Prepare More Reliable Antibody Drug Conjugates; Treatment for Irritable Bowel Syndrome Gets Approval from FDAIn This Issue1. SUBMENTAL CONTOURING INJECTABLE DRUG RECEIVES FDA NOD2. TREATMENT FOR IRRITABLE BOWEL SYNDROME GETS APPROVAL FROM FDA3. CHRONIC HEART FAILURE MEDICINE TO REDUCE HOSPITALIZATION RISK4. ANTIBODY DRUG CONJUGATE PLATFORM TO TREAT CANCER5. ADVANCES IN CANCER THERAPEUTICS THROUGH ANTIBODY-BASED TECHNOLOGY PLATFORM6. STRATEGIC PROCEDURE TO PREPARE MORE RELIABLE ANTIBODY DRUG CONJUGATES7. COMBINED ANTIBODY DRUG CONJUGATION THERAPY TO TREAT CANCER8. GLOBAL PATENTS FOR THE TREATMENT OF GOUTY ARTHRITIS9. TECHVISION 2015




Keyword1

Keyword2

Keyword3

Related Research

Release Date : 31-Oct-17

Region : Global

Release Date : 19-May-17

Region : Global

Release Date : 12-May-17

Region : Global

Release Date : 12-May-17

Region : Global

Related Subscription

• One-2-One Analyst briefing call •
• Access to published and new research deliverables •
• Mid year service review •
• Virtual Analyst briefing •
• GIL conference seats •

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.